tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Raghuram Selvaraju, 1058 are a BUY (93.13%), 75 are a HOLD (6.6%), 3 are a SELL (0.26%).
Analyst Raghuram Selvaraju, carries an average stock price target met ratio of 34.71% that have a potential upside of 65.55% achieved within 205 days. Previously, Raghuram Selvaraju worked at HC WAINWRIGHT.
Raghuram Selvaraju’s has documented 2,099 price targets and ratings displayed on 118 stocks. The coverage was on Healthcare, Basic Materials sectors.
Most recent stock forecast was given on BBIO, BridgeBio Pharma at 29-Aug-2025.
Analyst best performing recommendations are on CGTX (COGNITION THERAPEUTICS).
The best stock recommendation documented was for CGTX (COGNITION THERAPEUTICS) at 6/26/2025. The price target of $3 was fulfilled within 60 days with a profit of $2.68 (837.5%) receiving and performance score of 139.58.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
$7
$-8.04 (-53.46%)
$20
4 months 16 days ago
(17-Apr-2025)
8/12 (66.67%)
$-2.11 (-23.16%)
55
Buy
1 years 2 months 15 days ago
(18-Jun-2024)
10/37 (27.03%)
$101 (102.02%)
298
Sell
1 years 9 months 13 days ago
(20-Nov-2023)
1/3 (33.33%)
$-0.8 (-0.99%)
300
Hold
$20
$4.96 (32.98%)
$60
1 years 10 months 8 days ago
(25-Oct-2023)
3/22 (13.64%)
$5.72 (40.06%)
40
Hold
$25
$9.96 (66.22%)
$40
2 years 1 months 14 days ago
(19-Jul-2023)
2/5 (40%)
$3.4 (15.74%)
215
Which stock is Raghuram Selvaraju is most bullish on?
Which stock is Raghuram Selvaraju is most reserved on?
What Year was the first public recommendation made by Raghuram Selvaraju?
